Home
About
Overview
Sharing Data
ORCID
Help
History (70)
O'Donnell, Peter
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
Histopathologic changes in the extraocular muscle in centronuclear myopathy with a Dynamin 2 mutation.
3-Hydroxybutyric Acid
Comparing guidelines for the treatment of inflammatory bowel disease.
See All 70 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Comparing guidelines for the treatment of inflammatory bowel disease.
Comparing guidelines for the treatment of inflammatory bowel disease. Dig Dis. 2013; 31(3-4):360-2.
View in:
PubMed
subject areas
Aminosalicylic Acid
Calcineurin
Calcineurin Inhibitors
Enzyme Inhibitors
Humans
Inflammatory Bowel Diseases
Practice Guidelines as Topic
Tumor Necrosis Factor-alpha
authors with profiles
Stephen B. Hanauer